Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder

Brain Behav Immun. 2006 Mar;20(2):169-74. doi: 10.1016/j.bbi.2005.05.004. Epub 2005 Jul 14.

Abstract

Major depressive disorder is associated with increases in infectious disease risk as well as the incidence of inflammatory disorders. Declines of natural killer (NK) cell activity are reliably found in depression, whereas other studies report evidence of inflammation in depressed patients. The potential association between NK activity and circulating markers of immune activation has not been previously examined in the context of major depression. In this study, we measured levels of NK activity, circulating levels of interleukin-6 (IL-6), soluble interleukin-2 receptor, and acute phase proteins in 25 male patients with current major depressive disorder and 25 age, gender, and body weight comparable controls. As compared to controls, patients with major depressive disorder showed lower NK activity (p = .05) and higher circulating levels of IL-6 (p < .05). Levels of NK activity were not correlated with IL-6 or with other markers of immune activation. The independent effect of depression on inflammatory markers and natural killer immune responses has implications for understanding individual differences in the adverse health effects of major depressive disorder.

Publication types

  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / analysis
  • Adult
  • Analysis of Variance
  • Biomarkers / blood
  • Depressive Disorder, Major / blood
  • Depressive Disorder, Major / immunology*
  • Humans
  • Interleukin-6 / blood*
  • Killer Cells, Natural / immunology*
  • Lymphocyte Count
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Orosomucoid / analysis
  • Receptors, Interleukin-2 / blood
  • Reference Values
  • Statistics, Nonparametric

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • Interleukin-6
  • Orosomucoid
  • Receptors, Interleukin-2